Our leadership team has extensive experience in developing, obtaining regulatory approvals for and successfully commercializing a variety of oncology products. In total, they have decades of combined experience spanning a range of cancers and other diseases.

Grant Bogle

Senior Vice President, Chief Commercial Officer

Grant C. Bogle has served as our Senior Vice President and Chief Commercial Officer since July 2015. Prior to joining TESARO, Mr. Bogle was Senior Vice President, Pharmaceutical and Biotech Solutions at McKesson Specialty Health, where he led the informatics, health economics and outcomes research, reimbursement access and safety services, and U.S. oncology clinical research business units. Previously, he was Senior Vice President of Sales and Marketing for Millennium Pharmaceuticals, where he was responsible for the oncology product VELCADE. Prior to joining Millennium, Mr. Bogle held senior sales and marketing roles with Roche Pharmaceuticals, Knoll Pharmaceuticals, DuPont and American Critical Care (a division of American Hospital Supply Corp). He holds a masters of business administration from Columbia University and an undergraduate degree in economics from Dartmouth College.